{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:01:12Z","timestamp":1791874872688,"version":"4.3.4"},"reference-count":74,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a multifactorial condition that affects 25% of the world\u2019s population. There is a clear difference in both geographical distribution and sex in childbearing age. These differences are reduced when women become older and senescence begins. The factors that affect the likelihood of developing NAFLD in a premenopausal woman are an imbalance of sex hormones (especially in estradiol and androgen), microbiome dysregulation, insulin resistance, early menarche, the length of time that the woman breastfeeds for and polycystic ovarian syndrome (PCOS). The aim of this review is to identify various physical ailments that may not appear to be serious to young women but that then affect the onset of NAFLD in perimenopause and can degenerate into NASH. These conditions should also be considered in future clinical management, as well as in research opportunities, in order to customize the monitoring and treatment of NAFLD, considering gender medicine for those women who had early metabolic symptoms that were not considered to be significant at the time.<\/jats:p>","DOI":"10.3390\/biomedicines10051184","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T13:56:12Z","timestamp":1653054972000},"page":"1184","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6769-9520","authenticated-orcid":false,"given":"Livianna","family":"Carrieri","sequence":"first","affiliation":[{"name":"Personalized Medicine Laboratory, National Institute of Gastroenterology IRCCS \u201cS. de Bellis\u201d Research Hospital, Via Turi 27, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4232-8760","authenticated-orcid":false,"given":"Alberto","family":"Osella","sequence":"additional","affiliation":[{"name":"Laboratory of Epidemiology and Biostatistics, National Institute of Gastroenterology IRCCS \u201cS. de Bellis\u201d Research Hospital, Via Turi 27, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0262-707X","authenticated-orcid":false,"given":"Fausto","family":"Ciccacci","sequence":"additional","affiliation":[{"name":"UniCamillus Saint Camillus International, University of Health Sciences, Via di Sant\u2019Alessandro 8, 00131 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Giannelli","sequence":"additional","affiliation":[{"name":"Scientific Direction, National Institute of Gastroenterology IRCCS \u201cS. de Bellis\u201d Research Hospital, Via Turi 27, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0812-4441","authenticated-orcid":false,"given":"Maria","family":"Scavo","sequence":"additional","affiliation":[{"name":"Personalized Medicine Laboratory, National Institute of Gastroenterology IRCCS \u201cS. de Bellis\u201d Research Hospital, Via Turi 27, 70013 Castellana Grotte, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","article-title":"NAFLD in Asia\u2014As common and important as in the West","volume":"10","author":"Farrell","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ncp.10449","article-title":"Evolution of NAFLD and Its Management","volume":"35","author":"Mundi","year":"2019","journal-title":"Nutr. Clin. Pr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Neuschwander-Tetri, B.A. (2017). Non-alcoholic fatty liver disease. BMC Med., 15.","DOI":"10.1186\/s12916-017-0806-8"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v20.i10.2515","article-title":"Hepatic inflammation and progressive liver fibrosis in chronic liver disease","volume":"20","author":"Czaja","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"837419","DOI":"10.1155\/2010\/837419","article-title":"Inflammatory Mediators of Hepatic Steatosis","volume":"2010","author":"Hijona","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11522","DOI":"10.3748\/wjg.v21.i41.11522","article-title":"Inflammatory status in human hepatic cirrhosis","volume":"21","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2362.2009.02161.x","article-title":"Metabolic diseases and associated complications: Sex and gender matter!","volume":"39","author":"Handisurya","year":"2009","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cmet.2017.01.006","article-title":"Sex Differences: A Resultant of an Evolutionary Pressure?","volume":"25","author":"Maggi","year":"2017","journal-title":"Cell Metab."},{"key":"ref_12","first-page":"13","article-title":"Energy metabolism and fertility\u2014A balance preserved for female health","volume":"10","author":"Benedusi","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.dld.2008.12.099","article-title":"Possible involvement of androgen receptor alterations in hepatocarcinogenesis","volume":"41","author":"Barone","year":"2009","journal-title":"Dig. Liver Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.dld.2008.02.007","article-title":"Ep-idemiological data demonstrate that HCC is prevalent in men compared to women","volume":"41","author":"Barone","year":"2009","journal-title":"Dig. Liver Dis."},{"key":"ref_15","first-page":"105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease in Young Women with Polycystic Ovary Syndrome","volume":"91","author":"Setji","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"47","author":"Cerda","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00125-010-2009-0","article-title":"Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes","volume":"54","author":"Forbes","year":"2010","journal-title":"Diabetologia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.annepidem.2012.12.002","article-title":"Association between history of abortion and nonalcoholic fatty liver disease in middle-aged and elderly Chinese women","volume":"23","author":"Liu","year":"2013","journal-title":"Ann. Epidemiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","author":"Vassilatou","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_21","first-page":"268","article-title":"Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease","volume":"36","author":"Ludvigsson","year":"2015","journal-title":"Liver Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.maturitas.2018.06.013","article-title":"Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome","volume":"116","author":"Vassilatou","year":"2018","journal-title":"Maturitas"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kumarendran, B., O\u2019Reilly, M.W., Manolopoulos, K.N., Toulis, K.A., Gokhale, K.M., Sitch, A.J., Wijeyaratne, C.N., Coomarasamy, A., Arlt, W., and Nirantharakumar, K. (2018). Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002542"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhep.2018.09.013","article-title":"Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women Veeral","volume":"70","author":"Ajmera","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.cgh.2020.09.045","article-title":"Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD","volume":"19","author":"Sarkar","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/liv.14563","article-title":"The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease","volume":"40","author":"Jung","year":"2020","journal-title":"Liver Int."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"641446","DOI":"10.3389\/fendo.2021.641446","article-title":"SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and\/or Hirsutism and in Women with Sexual Dysfunction","volume":"12","author":"Maseroli","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","article-title":"Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"131528","DOI":"10.1155\/2015\/131528","article-title":"The influence of metabolic factors for nonalcoholic Fatty liver disease in women","volume":"2015","author":"Chung","year":"2015","journal-title":"Biomed Res. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"della Torre, S. (2021). Beyond the x factor: Relevance of sex hormones in nafld pathophysiology. Cells, 10.","DOI":"10.3390\/cells10092502"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Calabrese, F.M., Disciglio, V., Franco, I., Sorino, P., Bonfiglio, C., Bianco, A., Campanella, A., Lippolis, T., Pesole, P.L., and Polignano, M. (2022). A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients. Nutrients, 14.","DOI":"10.3390\/nu14091773"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Liu, L., Fu, Q., Li, T., Shao, K., Zhu, X., Cong, Y., and Zhao, X. (2022). Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0262855"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cca.2021.10.014","article-title":"Gut micro-biome and metabolic response in non-alcoholic fatty liver disease","volume":"523","author":"Abuwani","year":"2021","journal-title":"Clin. Chim. Acta."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Park, E., Jeong, J.J., Won, S.M., Sharma, S.P., Gebru, Y.A., Ganesan, R., Gupta, H., Suk, K.T., and Kim, D.J. (2021). Gut Microbio-ta-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease. Cells, 10.","DOI":"10.3390\/cells10102634"},{"key":"ref_36","first-page":"344","article-title":"Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre\/loxP system","volume":"223","author":"Liu","year":"2010","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_37","first-page":"55","article-title":"Growth hormone and bone","volume":"19","author":"Ohlsson","year":"1998","journal-title":"Endocr. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e18440","DOI":"10.1097\/MD.0000000000018440","article-title":"Human growth hormone level decreased in women aged <60 years but increased in men aged >50 years","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.beem.2017.10.009","article-title":"Endocrine rhythms of growth hormone release: Insights from animal studies","volume":"31","author":"Steyn","year":"2017","journal-title":"Best Pr. Res. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1210\/jcem-73-5-1099","article-title":"Naloxone Increases the Frequency of Pulsatile Luteinizing Hormone Secretion in Women with Hyperprolactinemia","volume":"73","author":"Cook","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","first-page":"2460","article-title":"An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women","volume":"81","author":"Veldhuis","year":"1996","journal-title":"J. Clin. Endocrinol Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ghir.2018.09.001","article-title":"A useful model to compare human and mouse growth hormone gene chromosomal structure, expression and regulation, and immune tolerance of human growth hormone analogues","volume":"42\u201343","author":"Cattini","year":"2018","journal-title":"Growth Horm. IGF Res."},{"key":"ref_43","unstructured":"Garcia, J.M., Merriam, G.R., and Kargi, A.Y. (2019). Growth Hormone in Aging, Endotex."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.steroids.2017.03.001","article-title":"Age- and menopause-related differences in subcutaneous adipose tissue estrogen receptor mRNA expression","volume":"121","author":"Park","year":"2017","journal-title":"Steroids"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11901-019-00495-9","article-title":"NAFLD in Women: Unique Pathways, Biomarkers, and Therapeutic Opportunities","volume":"18","author":"Yuan","year":"2019","journal-title":"Curr. Hepatol. Rep."},{"key":"ref_46","first-page":"271","article-title":"Androgen Receptor Defects: Histori-cal, Clinical, and Molecular Perspectives","volume":"16","author":"Quigley","year":"1995","journal-title":"Endocr. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","article-title":"Testosterone, Sex HormoneBinding Globulin and Nonalco-holic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"16","author":"Jaruvongvanich","year":"2017","journal-title":"Ann. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ajg.2017.44","article-title":"For the Coronary Artery Risk Development in Young Adults (CARDIA) Cohort Testosterone Levels in Pre-Menopausal Women are Associated with Nonalcoholic Fatty Liver Disease in Midlife","volume":"112","author":"Sarkar","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"792920","DOI":"10.3389\/frph.2021.792920","article-title":"Androgens, Endometriosis and Pain","volume":"3","author":"Evans","year":"2021","journal-title":"Front. Reprod. Health"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","article-title":"Gender and Racial Differences in Nonalcoholic Fatty Liver Disease","volume":"6","author":"Pan","year":"2014","journal-title":"World J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cgh.2016.07.034","article-title":"Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohep-atitis","volume":"15","author":"Yang","year":"2017","journal-title":"Clin. Gastroenterol Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/gme.0b013e318198d6b2","article-title":"Cortisol Levels during the Menopausal Transition and Early Postmenopause: Observations from the Seattle Midlife Women\u2019s Health Study","volume":"16","year":"2009","journal-title":"Menopause"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/ijo.2015.102","article-title":"Estrogens protect male mice from obesity complications and influence glucocorticoid metabolism","volume":"39","author":"Dakin","year":"2015","journal-title":"Int. J. Obes."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1055\/a-1341-9710","article-title":"Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic Syndrome","volume":"53","author":"State","year":"2021","journal-title":"Horm. Metab. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1515\/jpem-2020-0684","article-title":"Early menarche is associated with insu-lin-resistance and non-alcoholic fatty liver disease in adolescents with obesity","volume":"34","author":"Grandone","year":"2021","journal-title":"J. Pediatric Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and In-herent Cardiovascular Risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/oby.20950","article-title":"Earlier men-arche is associated with fatty liver and abdominal ectopic fat in midlife, independent of young adult BMI: The CARDIA study","volume":"23","author":"Mueller","year":"2015","journal-title":"Obesity"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Spremovi\u2019c Radenovi\u2019c, S., Pupovac, M., Andji\u2019, M., Bila, J., Sre\u2019ckovi, S., Gudovi, A., Draga\u0161, B., and Radunovi, N. (2022). Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic OvarySyndrome (PCOS). Biomedicines, 10.","DOI":"10.3390\/biomedicines10010131"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00535-010-0311-8","article-title":"Prevalence, gender, ethnic variations, and prognosis of NASH","volume":"46","author":"Hashimoto","year":"2010","journal-title":"J. Gastroenterol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1665-2681(19)31616-3","article-title":"Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens","volume":"9","author":"Ramos","year":"2010","journal-title":"Ann. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jgh3.12512","article-title":"Non-alcoholic fatty liver disease in premenopausal women with pol-ycystic ovary syndrome: A systematic review and meta-analysis","volume":"5","author":"Shengir","year":"2021","journal-title":"JGH Open."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.1210\/clinem\/dgac068","article-title":"Long or Irregular Menstrual Cycles and Risk of Prevalent and Incident Nonalcoholic Fatty Liver Disease","volume":"107","author":"Cho","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.eurox.2019.100060","article-title":"Polycystic ovary syndrome (PCOS) and genetic predisposition: A review article","volume":"3","author":"Ajmal","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol. X"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: Current perspectives and recent advances","volume":"241","author":"Lau","year":"2016","journal-title":"J. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1266Y1271","DOI":"10.1096\/fj.04-3580com","article-title":"Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)","volume":"19","author":"Song","year":"2005","journal-title":"FASEB J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1096\/fj.07-8227com","article-title":"PhosphatidylethanolamineN-methyltransferase(PEMT)gene expression is induced by estrogen in human and mouse primary hepatocytes","volume":"21","author":"Resseguie","year":"2007","journal-title":"FASEB J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3945\/an.114.007955","article-title":"Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes","volume":"7","author":"Sherriff","year":"2016","journal-title":"Adv. Nutr. Int. Rev. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13098-021-00710-y","article-title":"Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes","volume":"13","author":"You","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4172\/2155-9899.1000523","article-title":"Investigating molecular connections of non-alcoholic fatty liver disease with associated pathological conditions in West Virginia for biomarker analysis","volume":"8","author":"Sharma","year":"2017","journal-title":"J. Clin. Cell Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance","volume":"12","author":"Misu","year":"2010","journal-title":"Cell Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"633703","DOI":"10.3389\/fnut.2021.633703","article-title":"Alcohol Intake Is Associated with Elevated Serum Levels of Selenium and Selenoprotein P in Humans","volume":"8","author":"Isobe","year":"2021","journal-title":"Front. Nutr."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Suliga, E., Ciesla, E., Gluszek-Osuch, M., Lysek-Gladysinska, M., Wawrzycka, I., and Gluszek, S. (2020). Breastfeeding and Prevalence of Metabolic Syndrome among Perimenopausal Women. Nutrients, 12.","DOI":"10.3390\/nu12092691"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1002\/hep.32034","article-title":"The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study","volume":"74","author":"Park","year":"2021","journal-title":"Hepatology"},{"key":"ref_74","first-page":"378","article-title":"Breastfeeding duration and reduced risk of NAFLD in midlife of parous women","volume":"2","author":"Mantovani","year":"2021","journal-title":"Explor. Med."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1184\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:15:28Z","timestamp":1760138128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["biomedicines10051184"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10051184","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]}}}